Aptar Pharma, part of AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that its LuerVax ® intranasal ...
Aptar today announced the expansion of its operations in Mumbai, India to add local production of several pharma inhalation technologies, including Aptar’s pressurized metered dose inhaler (pMDI) ...
Particulate contamination and product cleanliness are primary concerns in the pharmaceutical market. The latest EMA GMP Annex 1 revision requires that pharmaceutical companies establish more stringent ...
Aptar Beauty and BVLGARI launch Le Gemme Tygar Travel Spray using Nomad Refill, a refillable 10 ml travel spray that connects directly to a full-size perfume bottle through a patented integrated ...
In this interview, Edouard Pagnoud, Product Line Manager for Vial Stoppers at Aptar Pharma, discusses the evolving expectations for elastomeric closures under USP <382>. He explains the importance of ...
Aptar Beauty and BVLGARI won the Formes de Luxe Award 2026 in the Refill category. The Le Gemme Tygar Travel Spray is a custom luxury fragrance mini packaging based on the Nomad Refill technology.
Aptar Pharma, a global leader in drug delivery, dosing and protection technologies and services, today announced a new research collaboration with Macquarie University under an Australian Research ...
Aptar Beauty’s sampling solutions and mini packaging provide reliable dispensing, portability, and a consistent brand experience. Our portfolio includes paper-based fragrance sampling, spray vials, ...
Submit your email address below and stay up to date with the latest industry insights.
Why are developers increasingly reconsidering dual-dose delivery strategies, and when do they make the most sense? The question is no longer whether systemic nasal delivery can succeed commercially.
As more cough and cold products move towards self-selection, a nasal spray must do more than deliver an accurate dose. It should also feel intuitive, comfortable, and reassuring to use. This article ...
How Can Human Imaging Improve Confidence in Nose-to-Brain Drug Development? Nose-to-brain (N2B) drug delivery has long attracted interest as a non-invasive approach for delivering therapies to the ...